By probing tyrosinase expression in the tumor bulk, melanoma cells (TYROSINASE-positive cells) were selected, which demonstrated higher levels of BMAL1 expression and increased frequency of BMAL1-positive cells (Fig. 5 c, d). This evidence concerns the gene TYR and melanoma.